CSF3 and cancer: Indeed, it has been well described that within an heterogeneous population of CD66-positive neutrophils (either LDN or NDN) CD10 can be used to discriminate mature from immature neutrophils populations in G-CSF-treated donors or in patients with cancer or in systemic lupus erythematosus (46).